June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
One Year Quality of Vision Outcomes from a Prospective, Randomized Eye-to-Eye Comparison of Wavefront guided and Wavefront optimized Laser in Situ Keratomileusis (LASIK) using the WaveLight® Allegretto Eye-Q 400 Hz
Author Affiliations & Notes
  • Christopher Sáles
    Ophthalmology, Stanford, Palo Alto, CA
  • Edward Manche
    Ophthalmology, Stanford, Palo Alto, CA
  • Footnotes
    Commercial Relationships Christopher Sáles, None; Edward Manche, Seros Medical, LLC (I), Calhoun Vision, Inc (I), Gerson Lehrman (C), Best Doctors (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3141. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher Sáles, Edward Manche; One Year Quality of Vision Outcomes from a Prospective, Randomized Eye-to-Eye Comparison of Wavefront guided and Wavefront optimized Laser in Situ Keratomileusis (LASIK) using the WaveLight® Allegretto Eye-Q 400 Hz. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3141.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the quality of vision outcomes of wavefront (WF) guided and WF optimized LASIK.

Methods: Seventy-two eyes of 36 subjects with myopia with or without astigmatism were randomized to receive either WF guided or WF optimized LASIK with the WaveLight® Allegretto Eye-Q 400 Hz excimer laser platform. WF guided treatments were planned using the Alcon Wavelight Allegro Analyzer (Alcon, Inc., Hüenberg, Switzerland). LASIK flaps were created using the 150-kHz IntraLase iFS (Abbott Medical Optics, Santa Ana, California). Patients were evaluated preoperatively and postoperatively at months 1, 3, 6, and 12. Evaluations included measurement of best spectacle corrected visual acuity (BSCVA) under controlled 5% and 25% contrast sensitivity conditions (Precision Vision, La Salle, Illinois). Patients also completed a questionnaire detailing subjective symptoms, which included quantitative grading on a scale of 0 (no symptoms) to 10 (severe symptoms) for each of the following parameters: glare under night and day conditions, haze, halos, clarity under night and day conditions, dry eye symptom frequency and severity, foreign body sensation, vision fluctuation, and ghosting. The LASIK surgeries were performed in a bilateral simultaneous fashion to negate any learning curve. Data are presented for month 12.

Results: Preoperative data showed no statistically significant differences between the WF guided and WF optimized groups for the parameters of uncorrected visual acuity (UCVA), BSCVA, 5% and 25% contrast sensitivity, and all questionnaire variables (all P>0.05). At postoperative month 12, there were no statistically significant differences between the groups with respect to 5% and 25% contrast sensitivity (WFG vs. WFO: 0.23 ± 0.16 vs. 0.26 ± 0.16; 0.23 ± 0.16 vs. 0.22 ± 0.08 logMAR; P=0.78, P=0.74, respectively), and all of the subjective symptoms evaluated on the questionnaire (all P>0.05).

Conclusions: There were no differences at 12 months in quality of vision outcomes between WF guided and WF optimized LASIK using the WaveLight® Allegretto Eye-Q 400 Hz excimer laser platform in myopic patients with or without astigmatism.

Keywords: 683 refractive surgery: LASIK • 684 refractive surgery: optical quality • 679 refractive surgery: comparative studies  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×